ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
99 438,72
-1,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. E-therapeutics Plc (ETX) Cours

E-therapeutics Plc

E-therapeutics Plc (ETX)

Eaton Vance Municipal Income 2028 Term Trust
Maurel Et Prom
9,00
0,00
(0,00%)
Fermé 02 Février 5:30PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
9,00
Prix Achat
9,00
Prix Vente
9,50
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
8,80 Plage de 52 semaines 18,50
Cap du marché
52,546M
Clôture Veille
9,00
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
0,00
Actions en circulation
583 844 162
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,71
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
318k
Bénéfice net
-11,17M

À propos de E-therapeutics Plc

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
www.etherapeutics.co.uk
Siège social
London, Gbr
Fondé
-
E-therapeutics Plc est coté dans le secteur Coml Physical, Biologcl Resh de la London Stock Exchange avec le ticker ETX. Le dernier cours de clôture d'E-therapeutics était de 9,00p. Au cours de la dernière année, les actions de E-therapeutics ont été négociées dans une fourchette de prix de 8,80p à 18,50p.

E-therapeutics compte actuellement 583 844 162 actions en circulation. La capitalisation boursière d'E-therapeutics est de £52,55 million. E-therapeutics a un ratio cours/bénéfice (ratio PE) de -4.71.

ETX Dernières nouvelles

Plus de nouvelles

e-therapeutics Announces Business Updates and Interim Results

e-therapeutics Announces Business Updates and Interim Results LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to...

31 Octobre 2024
UK Regulatory

AIM Cancellation - e-Therapeutics Plc

AIM 09 May 2024   NOTICE   09/05/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the company the following securities have been cancelled from trading...

09 Mai 2024
RNS Regulatory News

e-Therapeutics plc Last Day of Dealings on AIM

e-Therapeutics plc 08 May 2024       e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Last Day of Dealings on AIM     London, UK, 8 May 2024 - e-therapeutics plc (AIM:...

08 Mai 2024
RNS Regulatory News

FTSE Russell e-therapeutics

FTSE Russell 03 May 2024       E-therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 03 May 2024 Subject to the expected cancellation of trading on AIM for E-therapeutics...

03 Mai 2024
RNS Regulatory News

e-Therapeutics plc Result of General Meeting

e-Therapeutics plc 29 April 2024         e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Result of General Meeting  Matched Bargain Settlement Facility     London, UK, 29...

29 Avril 2024
RNS Regulatory News

e-Therapeutics says company faces lack of interest as UK listing

e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option ...

10 Avril 2024
Alliance News

e-Therapeutics plc Proposed Fundraise of £28.9m and Cancellation

e-Therapeutics plc 10 April 2024       This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue...

10 Avril 2024
RNS Regulatory News

e-Therapeutics plc Total Voting Rights

e-Therapeutics plc 31 January 2024     e-therapeutics plc ("e-therapeutics" or the "Company")   Total Voting Rights     London, UK, 31 January 2024 - e-therapeutics plc (AIM: ETX), a company...

31 Janvier 2024
RNS Regulatory News

e-Therapeutics plc Exercise of Options and Issue of Equity

e-Therapeutics plc 24 January 2024 e-therapeutics plc ("e-therapeutics" or the "Company") Exercise of Options and Issue of Equity London, UK, 24 January 2024 - e-therapeutics...

24 Janvier 2024
UK Regulatory

IN BRIEF: e-Therapeutics shares rise on strong financial year

C - Oxford, England-based computer-based drug discovery company - Says 2023 was "a year of significant execution and ...

16 Janvier 2024
Alliance News
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10099900DE
40099900DE
120099900DE
260099900DE
52-9.5-51.351351351418.518.58.823687311.11812046DE
156-24.9-73.451327433633.934.4822409816.9276855DE
2605.251403.7548.43.2557367317.94994848DE

ETX - Frequently Asked Questions (FAQ)

What is the current E-therapeutics share price?
The current share price of E-therapeutics is 9,00p
How many E-therapeutics shares are in issue?
E-therapeutics has 583 844 162 shares in issue
What is the market cap of E-therapeutics?
The market capitalisation of E-therapeutics is GBP 52,55M
What is the 1 year trading range for E-therapeutics share price?
E-therapeutics has traded in the range of 8,80p to 18,50p during the past year
What is the PE ratio of E-therapeutics?
The price to earnings ratio of E-therapeutics is -4,71
What is the cash to sales ratio of E-therapeutics?
The cash to sales ratio of E-therapeutics is 180
What is the reporting currency for E-therapeutics?
E-therapeutics reports financial results in GBP
What is the latest annual turnover for E-therapeutics?
The latest annual turnover of E-therapeutics is GBP 318k
What is the latest annual profit for E-therapeutics?
The latest annual profit of E-therapeutics is GBP -11,17M
What is the registered address of E-therapeutics?
The registered address for E-therapeutics is 4 KINGDOM STREET, PADDINGTON, LONDON
What is the E-therapeutics website address?
The website address for E-therapeutics is www.etherapeutics.co.uk
Which industry sector does E-therapeutics operate in?
E-therapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AIQAiq Limited
4,00p
(33,33%)
37,88k
INSPInspirit Energy Holdings Plc
0,0036p
(28,57%)
1,43B
ALKAlkemy Capital Investments Plc
175,00p
(27,27%)
176,27k
KNBKanabo Group Plc
1,00p
(25,00%)
461,04k
TCFTheracryf Plc
1,125p
(25,00%)
6,72M
MET1Metals One Plc
0,275p
(-35,29%)
16,2M
PPSProton Motor Power Systems Plc
0,175p
(-22,22%)
848,7k
SYMESupply@me Capital Plc
0,0025p
(-19,35%)
372,49M
CGNRConroy Gold & Natural Resources Plc
2,15p
(-18,87%)
739,53k
ONCOncimmune Holdings Plc
10,40p
(-16,47%)
1,19M
INSPInspirit Energy Holdings Plc
0,0036p
(28,57%)
1,43B
NTVONativo Resources Plc
0,0018p
(-5,26%)
1,41B
MSMNMosman Oil And Gas Limited
0,041p
(10,81%)
1,22B
TRPTower Resources Plc
0,0295p
(0,00%)
691,76M
SYMESupply@me Capital Plc
0,0025p
(-19,35%)
372,49M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
ETX
E-therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces